We serve as a catalyst for uniting research, industries, and philanthropy in pulmonary fibrosis to improve time to diagnosis and accelerate new therapies.
We are excited to announce that @YaleMed and @PittTweet have been selected to join the Three Lakes Consortium for Pulmonary Fibrosis (TLC4PF). Together we will focus on advancing disease understanding and accelerating new treatments for PF: https://t.co/zEBrCbnJbu
We have collaborated with @MayoClinic to advance diagnosis and treatment of pulmonary fibrosis. This collaboration will be led by Dr. Andrew Limper at the Mayo Clinic. https://t.co/l4oAMtaUl4
#ThreeLakesFoundation is collaborating with @MayoClinic to advance diagnosis and treatment of pulmonary fibrosis. This collaboration will be led by Dr. Andrew Limper at the Mayo Clinic. https://t.co/kSISxHanTy
Congratulations to my colleague and collaborator Sydney Montesi from @MGH_RI for her 2nd place award for her collagen targeted PET imaging of IPF from @ThreeLakes_TLF Innovation Challenge for Pulmonary Fibrosis. https://t.co/RBhQzqxdCu #IPF#MolecularImaging@MGHMartinos
Congratulations to the winners of the 2020 Innovation Challenge for Pulmonary Fibrosis! Read about the winners and their innovative solutions to accelerate diagnosing, treating, and managing pulmonary fibrosis. @ThreeLakes_TLF@MATTERhealth https://t.co/ar5QFNFVGW
1,468 people are waiting for a lung transplant. Hear the story of Nick Brown as he shares his journey getting diagnosed with pulmonary fibrosis and his struggle getting a double lung transplant in "Second Wind": https://t.co/hWIz0tc33n
Join @ThreeLakes_TLF and @MATTERhealth tomorrow for an all-day pitch day to hear finalists of the 2020 Pulmonary Fibrosis Innovation Challenge present solutions to expert judges for a chance at up to $50,000 and a free one-year membership at MATTER.
https://t.co/XPUonjfBpO
Dry cough is one of the most common, well-publicized early symptoms of #COVID19. Our CEO @wgerhart shares his thoughts on the stigma behind the cough associated with #PF that has been exacerbated by the #COVID pandemic. Read more here: https://t.co/jCil0kjEGP #PFcough
8/n And of course all our data is publicly available on the Gene Expression Omnibus (GEO) (GSE136831), and the results can be explored through the IPF Cell Atlas Data Mining portal https://t.co/6tpr5Cd8tU #CureIPF#datasharing#IPFCellAtlas https://t.co/B4jT1hfACG
1/n The #IPFCellAtlas is finally out! We profiled 312,928 cells from 32 IPF, 28 controls, 18 COPD lungs using @10xGenomics#scRNAseq & identified previously unidentified populations of epithelial & endothelial cells enriched in IPF #CureIPF https://t.co/nrNp2wXLzA
We've teamed up with @ThreeLakes_TLF to source & amplify stories of people living with #pulmonaryfibrosis. Select participants will win $500 and work with startups to help them create new #PF solutions. Learn more: https://t.co/614c12bL0V
#PFperspectives
Dr. Fernando Martinez of #WCMDeptOfMed is co-PI of the first #PrecisionMedicine research initiative to transform the diagnosis & treatment of interstitial lung diseases, particularly IPF
Funded by @nih_nhlbi in collaboration w/ @PFFORG & @3LakesPartners
https://t.co/JO1HlSSzvu
We've teamed up with @ThreeLakes_TLF to host the 2020 #PFinnovationchallenge. Innovators with solutions that advance disease awareness, preserve health & improve care for people living with #pulmonaryfibrosis are encouraged to apply. Learn more: https://t.co/pNQXi9qmo3